Why Are My CMT1A Symptoms Worse Than My Parent's?

It is very common for family members with Charcot-Marie-Tooth disease type 1A (CMT1A) to experience drastically different symptom severity, a concept doctors call intrafamilial variability ^[1][2]. Because CMT1A is a slowly progressive disease, a parent will typically have worse symptoms simply due to age. When a younger person experiences more severe symptoms than their parent, it is a strong signal to look for secondary factors ^[3].

Even though you and your parent share the exact same genetic duplication of the PMP22 gene, that duplication does not dictate your entire health profile. Your CMT1A symptoms might be more severe due to a combination of secondary health conditions, exposure to medications that harm nerves, differences in physical activity, or the presence of additional genetic factors ^[4][5][6]. Daily fluctuations also matter: on days when you are experiencing significant fatigue, your baseline gait abnormalities and weakness may temporarily feel much worse.

The Impact of Other Health Conditions

The health of your peripheral nerves depends on more than just your PMP22 gene. When a person with CMT1A develops another condition that also affects nerve health, it acts as a “double hit” to the nervous system.

• Diabetes and Metabolic Issues: Developing diabetes alongside CMT1A is known to significantly worsen symptoms. High blood sugar can independently damage nerves, and studies show that concurrent diabetes in CMT1A patients leads to an increased loss of nerve fibers and impairs the nerves’ ability to heal themselves ^[5].
• General Nerve Stressors: Conditions that put generalized stress on your body’s nerves can exacerbate CMT1A. This can include poorly controlled metabolic disorders or nutritional deficiencies ^[7].

Neurotoxic Medications and Supplements

People with CMT1A have nerves that are highly sensitive to certain medications. If you have been treated with drugs that have neurotoxic (nerve-damaging) side effects, this could explain a sharp increase in your symptom severity compared to your parent ^[8].

• Chemotherapy Drugs: Medications like vincristine, often used to treat cancer, are known to cause severe and sometimes irreversible worsening of neuropathy in people with CMT. In some cases, vincristine can even unmask severe symptoms in someone who previously had very mild or unnoticeable CMT ^[9][6].
• Over-the-Counter Supplements: Many patients with neuropathy try “nerve health” supplements that contain high doses of Vitamin B6 (pyridoxine). While normal dietary amounts are fine, high doses of Vitamin B6 are highly neurotoxic and can rapidly worsen neuropathy symptoms ^[10][11].
• Protecting Yourself: Because CMT is rare, many general practitioners and pharmacists are unaware of which specific drugs are contraindicated. It is highly recommended to download and carry a “Neurotoxic Drug List” (such as the one published by the Charcot-Marie-Tooth Association) to cross-reference every new prescription and supplement with your doctor ^[12].

Physical Activity and Joint Support

Differences in daily lifestyle and physical maintenance play a major role in how CMT1A affects your day-to-day life.

• Exercise: Regular physical activity has been shown to help manage CMT symptoms, maintain muscle strength, and improve overall function ^[13]. This includes progressive resistance exercise—which does not mean lifting heavy weights, but rather safely and gradually increasing light weights or resistance bands tailored to your specific abilities ^[14]. A more sedentary lifestyle can lead to faster muscle deconditioning.
• Specialized Physical Therapy: Seek out a physical therapist who has specific experience with neuromuscular diseases. Standard physical therapy regimens can sometimes overwork your already compromised (denervated) muscles, causing more harm than good ^[15].
• Orthotics: The use of tailored orthopaedic shoes and bracing (like AFOs) can significantly improve walking distance and reduce pain ^[14]. Differences in access to or use of these interventions can drastically alter how disabling the disease feels.

Secondary Genetic Factors (“Double Trouble”)

While the PMP22 duplication is the main driver of CMT1A, you inherit thousands of other genes from both parents.

• Additional Mutations: In some cases, a person might inherit the CMT1A duplication from one parent, but also inherit a completely different, secondary mutation in another neuropathy-related gene from either parent. When this happens, the co-occurrence can lead to much more extreme nerve damage than the PMP22 duplication alone ^[4][16].
• Genetic Modifiers: Researchers have also identified smaller genetic variations (modifiers) that do not cause disease on their own but can slightly increase or decrease the severity of CMT1A symptoms, though their overall impact is usually mild ^[17][18].